This material is intended to notify the press release issued on May 21 (local time) by Bristol Myers Squibb, our license partner for Opdivo.
 Please click for the original press release.


  • Original Link
  • Permalink


ONO Pharmaceutical Co. Ltd. published this content on 23 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 May 2024 02:04:08 UTC.